Nanomedicine pillars and monitoring nano-biointeractions

NanoScience and Technology

Volumn 61, Issue , 2012, Pages 27-56

  Karagkiozaki, V ^a   Logothetidis, S ^a   Vavoulidis, E ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84867032436     PISSN: 14344904     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-24181-9_2     Document Type: Article

References (104)

1. E. Kawasaki, A. Player, Nanotechnology, nanomedicine, and the development of new, effective therapies for cancer, Nanomed. Nanotechnol. Biol. Med. 1, 101-109 (2005)
2. S. Campos, R. Penson, R. Aisha, A. Mays, S. Ross, et al., The clinical utility of liposomal doxorubicin in recurrent ovarian cancer, Gynecol Oncol. 81, 206-212 (2001)
3. A. Nagayasu, K. Uchiyama, H. Kiwada, The size of liposomes: A factor which affects their targeting efficiency to tumors and therapeutic activity of liposomal antitumor drugs, Adv. Drug Deliv. Rev. 40, 75-87 (1999)
4. P. Goyal, K. Goyal, S. Kumar, A. Singh, et al., Liposomal drug delivery systems - Clinical applications, Acta Pharm. 55, 1-25 (2005)
5. A. Kim, E. Lee, S. Choi, C. Kim, In vitro and in vivo transfection efficiency of a novel ultradeformable cationic liposome, Biomaterials 25, 305-313 (2004)
6. V. Sirani, D. Koktysh, B. Yun, R. Matts, et al., Collagen coating promotes biocompatibility of semiconductor nanoparticles in stratifield LBL films, Nano Lett. 3, 1177-1182 (2003)
7. Y. Zhang, N. Kohler, M. Zhang, Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake, Biomaterials 23, 1553-1561 (2002)
8. O. Salata, Applications of nanoparticles in biology and medicine, J. Nanobiotechnol. 2, 3-6 (2004)
9. K. Win, S. Feng, In vitro and in vivo studies on vitamin E TPGS-emulsified poly (D,L-lacticco-glycolic acid) nanoparticles for paclitaxel formulation, Biomaterials 27, 2285-2291 (2006)
10. Y. Chen, C. Tsai, P. Huang, M. Chang, et al., Methotrexate conjugated to gold nanoparticles inhibits tumor growth in a syngeneic lungtumor model, Mol. Pharm. 4, 713-722 (2007)
11. B. Wilson, M. Samanta, K. Santh, K. Kumar, et al., Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease, Brain Res. 1200, 159-168 (2008)
12. A. Shahverdi, A. Fakhimi, H. Shahverdi, S. Minaian, Synthesis and effect of silver nanoparticles on the antibacterial activity of different antibiotics against Staphylococcus aureus and Escherichia coli, J. Nanomed. 3, 168-171 (2007)
13. A. Kumari, S.K. Yadav, S.C. Yadav, Biodegradable polymeric nanoparticles based drug delivery systems, Colloids Surf. B Biointerfaces 75, 1-18 (2010)
14. K. Unfried, C. Albrecht, L. Klotz, A. Von Mikecz, A. Grether, et al., Cellular responses to nanoparticles: Target structures and mechanisms, Nanotoxicology 1, 52-71 (2007)
15. D. Tomalia, Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging, Nanomed. Nanotechnol. Biol. Med. 2, 309 (2006)
16. A. Caminade, R. Laurent, J. Majoral, Characterization of dendrimers, Adv. Drug Deliv. Rev. 57, 2130-2146 (2005)
17. S. Svenson, D. Tomalia, Dendrimers in biomedical applications - Reflections on the field, Adv. Drug Deliv. Rev. 57, 2106-2129 (2005)
18. K. Ong, A. Jenkins, R. Cheng, D. Tomalia, et al., Dendrimer enhanced immunosensors for biological detection, Anal. Chim. Acta. 444, 143-148 (2001)
19. U. Boas, P. Hegaard, Dendrimers in drug research, Chem. Soc. Rev. 33, 43-63 (2004)
20. N. Kam, M. O'Connel, J. Wisdom, H. Dai, Carbon nanotubes as multifunctional biological transporters and near-infrared agents for selective cancer cell destruction, Proc. Natl. Acad. Sci. USA 102, 11600-11605 (2005)
21. P. Tran, L. Zhang, T. Webster, Carbon nanofibers and nanotubes in regenerative medicine, Adv. Drug Deliv. Rev. 61, 1097-1114 (2009)
22. N. Kam, Z. Dai, Carbon nanotubes as intracellular transporters for proteins and DNA: An investigation of the uptake mechanism and pathway, Angew. Chem. Internat. Ed. 45, 577-581 (2006)
23. A. Bianco, K. Kostarelos, M. Prato, Applications of carbon nanotubes in drug delivery, Curr. Opin. Chem. Biol. 9, 674-679 (2005)
24. J. Stoltz, Regenerative medicine: from engineering to clinical applications, J. Biomech. 39, 54 (2006)
25. S. Sundelacruz, D. Kaplan, Stem cell- and scaffold-based tissue engineering approaches to osteochondral regenerative medicine, Semin. Cell Dev. Biol. 20, 646-655 (2009)
26. P. Ma, Tissue engineering, in Encyclopedia of Polymer Science and Technology, vol. 12, 3rd. edn. Ed. by J.I. Kroschwitz (Wiley, Hoboken, NJ, 2005), pp. 261-291
27. S. Stephan, S. Ball, M. Williamson, D. Bax, et al., Cell - matrix biology in vascular tissue engineering, J. Anat. 209, 495-502 (2006)
28. B. Isenberg, C. Williams, R. Tranquillo, Small, diameter artificial arteries engineered in vitro, J. Circ. Res. 98, 25-35 (2006)
29. B. Ratner, Proteins controlled with precision at organic, polymeric, and biopolymer interfaces for tissue engineering and regenerative medicine, Principles Regenerat. Med. 1, 734-742 (2008)
30. E. Anitua, M. Sanchez, G. Orive, Potential of endogenous regenerative technology for in situ regenerative medicine, Adv. Drug Deliv. Rev. 62, 741-752 (2010)
31. M. Murata, S. Tohyama, K. Fukuda, Impacts of recent advances in cardiovascular regenerative medicine on clinical therapies and drug discovery, J. Pharmacol. Therapeut. 126, 109-118 (2010)
32. Shupe T, Petersen B. Potential applications for cell regulatory factors in liver progenitor cell therapy. Inter J of Biochemistry & Cell Biology, 43, 214-221 (2011)
33. M. Furth, A. Atala, Current and future perspectives of regenerative medicine, in Principles of Regenerative Medicine, 1st edn. (Academic, New York, 2008), pp. 2-15
34. N. Kimelman, G. Pelled, G. Helm, et al., Review: gene-and stem cell-based therapeutics for bone regeneration and repair, Tissue Eng. 13, 1135-1150 (2007)
35. S. Li, L. Wang, H. Jiang, et al., Stem cell engineering for treatment of heart diseases: potentials and challenges, Cell Biol. Int. 33, 255-267 (2009)
36. D. Sheyn, O. Mizrahi, S. Benjamin, Z. Gazit, et al., Genetically modified cells in regenerative medicine and tissue engineering, Adv. Drug Deliv. Rev. 62, 683-698(2010)
37. R. Jaenisch, R. Young, Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming, Cell 132, 567-582 (2008)
38. B. Feng, J. Ng, J. Heng, H. Ng, Molecules that promote or enhance reprogramming of somatic cells to induced pluripotent stem cells, Cell Stem Cell 4, 301-312 (2009)
39. I. Martin, D. Wendt, M. Heberer, The role of bioreactors in tissue engineering, Trends Biotechnol. 22, 80-86 (2004)
40. A. Khademhosseini, R. Langer, J. Borenstein, J. Vacanti, Microscale technologies for tissue engineering and biology, Proc. Natl. Acad. Sci. USA 103, 2480-2487 (2006)
41. J. Schakenraad, H. Busscher, Cell-polymer interactions: The influence of protein adsorption, Colloids Surf. 42, 331-343 (1989)
42. P. Yang, N. Huang, Y.X. Leng, J.Y. Chen, K.Y. Fu, S.C.H. Kwok, P.K. Leng, Y. Chu, Activation of platelets adhered on amorphous hydrogenated carbon films synthesized by plasma immersion ion implantation-deposition, Biomaterials 24, 2821-29 (2003)
43. http://klemkelab.ucsd.edu/research/cell.html
44. V. Shahin, N. Barrera, Providing unique insight into cell biology via atomic force microscopy, Int. Rev. Cytol. 265, 227-252 (2008)
45. N. Santos, M. Castanho, An overview of the biophysical applications of atomic force microscopy, Biophys. Chem. 107, 133-149 (2004)
46. C. Yip, Atomic force microscopy of macromolecular interactions, Curr. Opin. Struct. Biol. 11, 567-572 (2001)
47. D. Johnson, N. Hilal, R. Bowen, Basic principles of atomic force microscopy, Atom. Force Microsc. Process Eng. 1-30 (2009)
48. https://www.uclan.ac.uk/schools/computingengineeringphysical
49. D. Butterfield, T. Reed, F. Shelley, S. Newman, R. Sultana, Roles of amyloid "-peptideassociated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment, Free Radic. Biol. Med. 43, 658-677 (2007)
50. S. Sun, Y. Yue, X. Huang, D. Meng, Protein adsorption on blood-contact membranes, J. Membrane Sci. 222, 3-18 (2003)
51. X.D. Zhu, H.S. Fan, Y.M. Xiao, et al., Effect of surface structure on protein adsorption to biphasic calcium-phosphate ceramics in vitro and in vivo, Acta Biomater. 5, 1311-1318 (2009)
52. P. Cacciafesta, A. Humphris, K. Jandt, M. Miles, Human plasma fibrinogen adsorption on ultraflat titanium oxide surfaces studied with atomic force microscopy, Langmuir 16, 8167-8175 (2000)
53. J. Ortega-Vinuesa, P. Tengvall, et al., Aggregation of HSA, igg, and fibrinogen on methylated silicon surfaces, J. Colloid Interface Sci. 207, 228-239 (1998)
54. K. Mitsakakis, S. Lousinian, S. Logothetidis, Early stages of human plasma proteins adsorption probed by atomic force microscope, Biomol. Eng. 24, 119-124 (2007)
55. S. Logothetidis, Haemocompatibility of carbon based thin films, Diamond Relat. Mater. 16, 1847-1857 (2007)
56. S. Lousinian, S. Kassavetis, S. Logothetidis, Surface and temperature effect on fibrinogen adsorption to amorphous hydrogenated carbon thin films, Diamond Relat. Mater. 16, 1868-1874 (2007)
57. J.H. Hartwig, Platelet structure, in Platelets, ed. by A.D. Michelson (Academic, New York, 2002), pp. 37-45
58. T.I. Okpalugo, A.A. Ogwu, P.D. Maguire, J.A. McLaughlin, Platelet adhesion on silicon modified hydrogenated amorphous carbon films, Biomaterials 25, 239-245 (2004)
59. V. Karagkiozaki, S. Logothetidis, S. Lousinian, G. Giannoglou, Impact of surface electric properties of carbon-based thin films on platelets activation for nano-medical and nanosensing applications, Int. J. Nanomed. 3, 461-469 (2008)
60. T.S. Tsapikouni, Y.F. Missirlis, pH and ionic strength effect on single fibrinogen molecule adsorption on mica studied with AFM, Colloid Surf. B: Biointerfaces 57, 89-96 (2007)
61. Noy A. Interactions at solid-fluid interfaces, In: Liu, Xiang Yang; De Yoreo, James J. (Editors), Nanoscale structure and assembly at solid-fluid interfaces. Kluwer Academic Publishers, USA. Volume I, 2004, p. 57-64.
62. R. Mandic, C. Opper, J. Krappe, W. Wesemann, Platelet sialic acid as a potential pathogenic factor in coronary heart disease, Thrombosis Res. 106, 137-141 (2002)
63. D. Müller, K. Anderson, Biomolecular imaging using atomic force microscopy, Trends Biotechnol. 20, 545-49 (2002)
64. M. Hussain, A. Agnihotri, C. Siedlecki, AFM imaging of ligand binding to platelet integrin alphaiibbeta3 receptors reconstituted into planar lipid bilayers, Langmuir 19(21), 6979-86 (2005)
65. V. Karagkiozaki, S. Logothetidis, G. Giannoglou, Advances in stent coating technology via nanotechnology tools and process, Eur. J. Nanomed. 1, 24-28 (2008)
66. P.D. Maguire, J.A. McLaughlin, T.I.T. Okpalugo, P. Lemoine, P. Papakonstantinou, E.T. McAdams, M. Needham, A. Ogwu, et al., Mechanical stability, corrosion performance and bioresponse of amorphous diamond-like carbon for medical stents and guidewires, Diamond Relat. Mater. 14, 1277-88 (2005)
67. V. Karagkiozaki, S. Logothetidis, N. Kalfagiannis, S. Lousinian, G.A.F.M. Giannoglou, Probing platelets activation behavior on titanium nitride nanocoatings for biomedical applications, J. Nanomed. Nanotechnol. Biol. Med. 5, 64-72 (2009)
68. V. Karagkiozaki, S. Logothetidis, A. Laskarakis, G. Giannoglou, S.A.F.M. Lousinian, Study of the thrombogenicity of carbon-based coatings for cardiovascular applications, Mater. Sci. Eng. B 152, 16-21 (2008)
69. V. Karagkiozaki, S. Logothetidis, S. Kassavetis, S. Lousinian, Nanoscale characterization of biological and mechanical profile of carbon nanocoatings for stents, Eur. J. Nanomed. 2, 14-21 (2009)
70. S. Goodman, T. Grasel, S. Cooper, R.J. Albrecht, Biomed. Mater. Res. 23, 105 (1989)
71. V. Karagkiozaki, S. Logothetidis, S. Kassavetis, G. Giannoglou, Nanomedicine for the reduction of the thrombogenicity of stent coatings, Int. J. Nanomed. 5, 239-248 (2010)
72. S. Choudhary, M. Berhe, K. Haberstroh, T. Webster, Increased endothelial and vascular smooth muscle cell adhesion on nanostructured titanium and CoCrMo, Int. J. Nanomed. 1, 41-49 (2006)
73. P. Yang, N. Huang, Y.X. Leng, J.Y. Chen, K.Y. Fu, S.C.H. Kwok, Y. Leng, P.K. Chu, Activation of platelets adhered on amorphous hydrogenated carbon films synthesized by plasma immersion ion implantation-deposition, Biomaterials 24, 2821-29 (2003)
74. L. Leung, Role of thrombospondin in platelet aggregation, J. Clin. Invest. 74, 1764-1772 (1984)
75. J. Coligan, H. Slayter, Structure of thrombospondin, J. Biol. Chem. 259, 3944-3948 (1984)
76. H.C. Fischer, W.C. Chan, Nanotoxicity: the growing need for in vivo study, Curr. Opin. Biotechnol. 18, 565-571 (2007)
77. P. Borm, F.C. Klaessig, T.D. Landry, B. Moudgil, et al., Research strategies for safety evaluation of nanomaterials, part V: role of dissolution in biological fate and effects of nanoscale particles, Toxicol. Sci. 90, 23-32 (2006)
78. A. Nel, T. Xia, L. Maedler, N. Li, Toxic potential of materials at the nanolevel, Science 311, 622-627 (2006)
79. T. Xia, M. Kovochich, J. Brant, M. Hotze, et al., Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm, Nano Lett. 6, 1794-1807 (2006)
80. S. Caruthers, S. Wickline, G. Lanza, Nanotechnological applications in medicine, Curr. Opin. Biotechnol. 18, 26-30 (2007)
81. G. Oberdörster, A. Maynard, et al., Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy, Particle Fibre Toxicol. 2, 1-35 (2005)
82. J. Ryman Rasmussen, P. Jessica, et al., Penetration of intact skin by quantum dots with diverse physicochemical properties, Toxic. Sci. 91, 159-165 (2006)
83. S. Sinkle, J. Antonini, B. Rich, et al., Skin as a route of exposure and sensitization in chronic Beryllium disease, Environ. Health Perspect. 111, 1202-1218 (2003)
84. J. Ryman-Rasmussen, J. Riviere, N. Monteiro-Riviere, Variables influencing interactions of untargeted quantum dots nanoparticles with skin cells and identification of biochemical modulators, Nano Lett. 7, 1344-134 (2007)
85. Z. Liu, W. Cai, L. He, N. Nakayama, K. Chen, X. Sun, et al., In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice, Nat. Nano 2, 47-52 (2007)
86. S. Hong, P.R. Leroueil, E.K. Janus, J.L. Peters, M.M. Kober, et al., Interaction of polycationic polymers with supported lipid biolayers and cells: Nanoscale hole formation and enhanced membrane permeability, Bioconj. Chem. 17, 728-734 (2006)
87. P.R. Leroueil, S. Hong, A. Mecke, J.R. Baker, et al., Nanoparticle interaction with biological membranes: Does nanotechnology present a Janus face, Acc. Chem. Res. 40, 335-342 (2007)
88. D. Drobne, V. Kralj-Iglic, Lipid membranes as tools in nanotoxicity studies, Adv. Planar Lipid Bilayers Liposomes. 10, 121-134 (2009)
89. M. Geiser, B. Rothen-Rutishauser, N. Kapp, S. Schurch, et al., Ultrafine particles cross cellular membranes by nonphagocytic mechanisms in lungs and in cultured cells, Environ. Health Perspect. 113, 1555-1560 (2005)
90. L. Liu, T. Takenaka, A. Zinchenko, N. Chen, et al., Cationic silica nanoparticles are efficiently transferred into mammalian cells, Int. Symp. Micro-Nano Mechatron. Hum. Sci. 1-2, 281-285 (2007)
91. M. Chen, A. von Mikecz, Formation of nucleoplasmic protein aggregates impairs nuclear function in response to SiO2 nanoparticles, Exp. Cell Res. 305, 51-62 (2005)
92. N. Singh, B. Manshian, G. Jenkins, et al., nanogenotoxicology: The DNA damaging potential of engineered nanomaterials, Biomaterials 30, 3891-3914 (2009)
93. N. Li, C. Sioutas, A. Cho, et al., Ultrafine particulate pollutants induce oxidative stress and mitochondrial damage, Environ. Health Perspect. 111, 455-460 (2003)
94. Y. Pan, A. Leifert, D. Ruau, S. Neuss, et al., Gold nanoparticles of diameter 1,4 nm trigger necrosis by oxidative stress and mitochondrial damage, Small 5, 2067-2076 (2009)
95. L. Canesi, C. Ciacci, D. Vallotto, G. Gallo, A. Marcomini, G. Pojana, In vitro effects of suspensions of selected nanoparticles (C60 fullerene, tio2, sio2) on Mytilus hemocytes, Aquat. Toxicol. 31(96), 151-158 (2010)
96. A. Nel, et al., Toxic potential of materials at the nanolevel, Science 311, 622-627 (2006)
97. A. Maynard, Nanotechnology: assessing the risks, Nano Today. 1, 22-33 (2006)
98. S. Naqvi, M. Samim, et al., Concentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stress, Int. J. Nanomed. 5, 983-989 (2010)
99. M. Auffan, J. Rose, J. Bottero, et al., Towards a definition of inorganic nanoparticles from an environmental, health and safety perspective, Nat. Nanotechnol. 4, 634-642 (2009)
100. C. Poland, R. Duffin, I. Kinloch, et al., Carbon nanotubes introduced into the abdominal cavity ofmice show asbestos-like pathogenicity in a pilot study, Nat. Nanotechnol. 3, 423-428 (2008)
101. K. Kostarelos, The long and short of carbon nanotube toxicity, Nat. Biotechnol. 26, 774-776 (2008)
102. V. Kagan, N. Konduru, W.W. Feng, et al., Carbon nanotubes degraded by neutrophil myeloperoxidase induce less pulmonary inflammation, Nat. Nanotechnol. 1-6 (2010)
103. P. Dwivedi, A. Misra, R. Shanker, M. Das, Are nanomaterials a threat to the immune sysyem? Nanotoxicology 3, 19-26 (2009)
104. G. Tepe, J. Schmehl, P. Hans, et al., Reduced thrombogenicity of nitinol stents - In vitro evaluation of diff rent surface modifications and coatings, Biomaterials 27, 643-650 (2006)